Saving Minds
The future of medicine for Alzheimer’s and Parkinson’s diseases
10 months ago

Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies

This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.